Bupa Platinum consultant
Fee assured
Verified account
Open Referral network
Specialises in
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Pavlu is a consultant haematologist and an international expert in acute leukaemia and transplantation.
He is the acute leukaemia lead at Hammersmith Hospital, a world-leading haematology centre. He also has an interest in patients with relapsed or difficult-to-treat haematological malignancies.
Areas of interest
Bone marrow transplantation (BMT); CAR-T cell therapy, Blood cancer; Leukaemia (acute lymphoblastic leukaemia, acute myeloid leukaemia, chronic myeloid leukaemia), hairy cell leukaemia; abnormal, high or low neutrophil count, blasts, dysplastic changes, circulating blasts, increase of CD34 positive cells, high platelet count, iron deficiency, iron infusion; Stem cell transplants (SCT); Myelodysplastic syndromes (MDS); Chronic myelomonocytic leukaemia (CMML), chronic myelogenous leukemia (CML), Myeloproliferative neoplasms (MPN, MPD), JAK-2 positivity, BCR-ABL positivity, essential thrombocythaemia (ET), acute leukemia (AML, ALL), FTL-3 positive leukaemia. 5q minus MDS.
Medical secretaries
About me
External resources
- Dr Jiri Pavlu : http://pavlu.co.uk
- ICL : http://www.imperial.ac.uk/people/j.pavlu
Current NHS consultant posts held
Acute Leukaemia lead clinician at Hammersmith Hospital
Research interests
Acute leukaemia
Myelodysplastic syndromes
Bone marrow and stem cell transplants
(Additional) Languages spoken
Publications
Selected publications:
Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT. Journal of Hematological Oncology 2023
How I use measurable residual disease in the clinical management of adult acute lymphoblastic leukemia. Clinical Hematology International 2021
Augmented Reduced-Intensity Regimen Does Not Improve Post allogeneic Transplant Outcomes in Acute Myeloid Leukemia. Journal of Clinical Oncology 2021
Bone marrow versus mobilized peripheral blood stem cell graft in T- cell-replete haploidentical transplantation in acute lymphoblastic leukemia. Leukemia 2020
Association of uric acid levels before start of conditioning with mortality after alloSCT: a prospective, non-interventional study of the EBMT Transplant Complication Working Party. Haematologica 2020
Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality. Leukemia 2020
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. Journal of Hematological Oncology 2019
Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies. Clinical Nutrition 2018
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT. Cancer 2017
Fecal microbionta transplant: A novel biological approach to extensively drug-resistant organism-related non-relapse mortality. Bone Marrow Transplantation 2017
BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation. European Journal of Haematology 2017
C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early and long term mortality. British Journal of Haematology 2017
Treatment and management of graft-versus-host disease: improving response and survival. Therapeutic Advances in Hematology 2013
Three decades of transplantation for CML: what have we learnt? Blood 2011
About my work
View photos of my work
Click an image to enlarge and read a description
View videos on youtube
My qualifications & training
Qualifications
- FRCPath
Royal College of Pathologists 2007
- MD
Charles University, Prague and St. George's Hospital, London 1998
- MRCP (UK)
Royal College of Physicians 2002
- MUDr
First Faculty of Medicine, Charles University, Prague 1998
GMC registration
Reference number 5198896
Details of entry to specialist register
Affiliations / memberships
American Society of Hematology
British Society for Blood and Marrow Transplantation
European Blood and Marrow Transplantation Society
Inspector for JACIE (international transplantation accreditation body)
Royal College of Physicians
Royal College of Pathologists
My private practice
Practice hours
Practice
Day
Hours
Appt Bookings
- RB&HH Specialist Care, 77 Wimpole Street,...
- Wednesday
- 08:30
- 12:00
- 442083838117
- Sainsbury WingDu Cane RoadLONDONW12 0HS
- Monday
- 08:00
- 18:00
- 442083838117
- Sainsbury WingDu Cane RoadLONDONW12 0HS
- Tuesday
- 08:00
- 11:30
- 442083838117
- Sainsbury WingDu Cane RoadLONDONW12 0HS
- Wednesday
- 13:30
- 18:00
- 442083838117
- Sainsbury WingDu Cane RoadLONDONW12 0HS
- Thursday
- 08:00
- 17:00
- 442083838117
- Sainsbury WingDu Cane RoadLONDONW12 0HS
- Friday
- 08:00
- 18:00
- 442083838117
- The Thames View, Charing Cross Hospital, London
- Tuesday
- 18:00
- 19:30
- 442083838117
- The Thames View, Charing Cross Hospital, London
- Thursday
- 18:00
- 19:30
- 442083838117
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs
in line with Department of Health, GMC and appropriate professional bodies
guidelines.
In the event of an urgent query following treatment, Bupa members should use the
following contact details
Phone number - dedicated 24-hour telephone line and patient passport for direct admissions to haematology will be provided.
Launch
Website
Fee assured
Verified account
